COMPANY RESEARCHShanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical is a Chinese healthcare group with research, development, manufacturing and commercialization activities across pharmaceutical medicines and related healthcare businesses. Its innovative therapeutics work includes small-molecule drugs, biological medicines and collaborative development programs in oncology and other disease areas. The issuer is traded on both the Shanghai Stock Exchange and the Hong Kong Stock Exchange, which should be represented as two securities of a single listed group. Fosun Pharma also has businesses outside proprietary drug development, so the directory distinguishes its therapeutics activities from its wider corporate portfolio.
Company at a glance
Corporate information
- Company entity
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Headquarters / principal office
- China
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://www.fosunpharma.com/
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
SSE: 600196 HKEX: 02196
small molecules · antibody biologics · cell therapy
oncology · immunology · infectious diseases
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Shanghai Fosun Pharmaceutical is a Chinese healthcare group with research, development, manufacturing and commercialization activities across pharmaceutical medicines and related healthcare businesses. Its innovative therapeutics work includes small-molecule drugs, biological medicines and collaborative development programs in oncology and other disease areas. The issuer is traded on both the Shanghai Stock Exchange and the Hong Kong Stock Exchange, which should be represented as two securities of a single listed group. Fosun Pharma also has businesses outside proprietary drug development, so the directory distinguishes its therapeutics activities from its wider corporate portfolio.
Business, technology & evidence
- SecuritiesSSE: 600196 / HKEX: 02196
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ↗Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ·
- Official issuer and R&D disclosure · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ↗Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.